These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31990371)

  • 1. Higher levels of TNF and IL-4 cytokines and low miR-182 expression in visceral leishmaniasis-HIV co-infected patients.
    Barbosa Júnior WL; Justo AM; Aguiar Dos Santos AM; de Lorena VMB; do Carmo RF; de Melo FL; de Medeiros ZM; Vasconcelos LRS
    Parasite Immunol; 2020 Apr; 42(4):e12701. PubMed ID: 31990371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of disease severity in patients with visceral leishmaniasis co-infected with HIV.
    Ferreira GR; Santos-Oliveira JR; Silva-Freitas ML; Honda M; Costa DL; Da-Cruz AM; Costa CHN
    Cytokine; 2022 Jan; 149():155747. PubMed ID: 34715475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre- & post-treatment evaluation of immunological features in Indian visceral leishmaniasis (VL) patients with HIV co-infection.
    Sinha PK; Bimal S; Singh SK; Pandey K; Gangopadhyay DN; Bhattacharya SK
    Indian J Med Res; 2006 Mar; 123(3):197-202. PubMed ID: 16778304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 alters T helper cytokines, interleukin-12 and interleukin-18 responses to the protozoan parasite Leishmania donovani.
    Wolday D; Berhe N; Britton S; Akuffo H
    AIDS; 2000 May; 14(8):921-9. PubMed ID: 10853973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of serum cytokines in patients with visceral leishmaniasis and HIV-1 co-infection.
    Medrano FJ; Rey C; Leal M; Cañavate C; Rubio A; Sánchez-Quijano A; Alvar J; Lissen E
    Clin Exp Immunol; 1998 Dec; 114(3):403-7. PubMed ID: 9844050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of serum cytokine levels in symptomatic and asymptomatic HIV-Leishmania coinfected individuals from a Brazilian visceral leishmaniasis endemic area.
    Guedes DL; Silva EDD; Castro MCAB; Júnior WLB; Ibarra-Meneses AV; Tsoumanis A; Adriaensen W; van Griensven J; Pereira VRA; Medeiros ZM
    PLoS Negl Trop Dis; 2022 Jun; 16(6):e0010542. PubMed ID: 35714136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological factors, but not clinical features, predict visceral leishmaniasis relapse in patients co-infected with HIV.
    Takele Y; Mulaw T; Adem E; Shaw CJ; Franssen SU; Womersley R; Kaforou M; Taylor GP; Levin M; Müller I; Cotton JA; Kropf P
    Cell Rep Med; 2022 Jan; 3(1):100487. PubMed ID: 35106507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum chemokine profiles in visceral leishmaniasis, HIV and HIV/ visceral leishmaniasis co-infected Ethiopian patients.
    Sisay Z; Berhe N; Petros B; Tegbaru B; Messele T; Hailu A; Wolday D
    Ethiop Med J; 2011 Jul; 49(3):179-86. PubMed ID: 21991751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring prognosis in chronic relapsing visceral leishmaniasis among HIV-infected patients: Circulating Leishmania DNA.
    Cota GF; de Sousa MR; de Assis TSM; Pinto BF; Rabello A
    Acta Trop; 2017 Aug; 172():186-191. PubMed ID: 28501450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of anti-Leishmania IgG3 and low CD4
    Kuschnir RC; Pereira LS; Dutra MRT; de Paula L; Silva-Freitas ML; Corrêa-Castro G; da Costa Cruz Silva S; Cota G; Santos-Oliveira JR; Da-Cruz AM
    BMC Infect Dis; 2021 Apr; 21(1):369. PubMed ID: 33874901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular profile of cytokine production in a patient with visceral leishmaniasis: gammadelta+ T cells express both type 1 cytokines and interleukin-10.
    Lagler H; Willheim M; Traunmüller F; Wahl K; Winkler H; Ramharter M; Graninger W; Winkler S
    Scand J Immunol; 2003 Mar; 57(3):291-5. PubMed ID: 12641659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?
    Medrano FJ; Hernández-Quero J; Jiménez E; Pineda JA; Rivero A; Sánchez-Quijano A; Velez ID; Viciana P; Castillo R; Reyes MJ
    AIDS; 1992 Dec; 6(12):1499-503. PubMed ID: 1362880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine profiles amongst Sudanese patients with visceral leishmaniasis and malaria co-infections.
    van den Bogaart E; Talha AB; Straetemans M; Mens PF; Adams ER; Grobusch MP; Nour BY; Schallig HD
    BMC Immunol; 2014 May; 15():16. PubMed ID: 24886212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Levels of Soluble CD40 Ligand and Neopterin in HIV Coinfected Asymptomatic and Symptomatic Visceral Leishmaniasis Patients.
    Adriaensen W; Abdellati S; van Henten S; Gedamu Y; Diro E; Vogt F; Mengesha B; Adem E; Kestens L; van Griensven J
    Front Cell Infect Microbiol; 2018; 8():428. PubMed ID: 30619775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine expression during syphilis infection in HIV-1-infected individuals.
    Knudsen A; Benfield T; Kofoed K
    Sex Transm Dis; 2009 May; 36(5):300-4. PubMed ID: 19265730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral leishmaniasis as an independent cause of high immune activation, T-cell senescence, and lack of immune recovery in virologically suppressed HIV-1-coinfected patients.
    Casado JL; Abad-Fernández M; Moreno S; Pérez-Elías MJ; Moreno A; Bernardino JI; Vallejo A
    HIV Med; 2015 Apr; 16(4):240-8. PubMed ID: 25604328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of host immune status by cryptococcus co-infection during HIV-1 pathogenesis and its impact on CD+4 cell and cytokines environment.
    Linyu L; Ali Abuderman AW; Muzaheed ; Acharya S; Divakar DD
    Microb Pathog; 2020 Feb; 139():103864. PubMed ID: 31715319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment effects on IL-9+CD4+ T cells and the cytokines influencing IL-9 production in paediatric visceral leishmaniasis.
    Moravej A; Choopanizadeh M; Pourabbas B; Pouladfar G; Kalani M
    Parasite Immunol; 2020 Dec; 42(12):e12787. PubMed ID: 32810296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral Leishmaniasis/HIV co-infection in northeast Brazil: evaluation of outcome.
    Távora LG; Nogueira MB; Gomes ST
    Braz J Infect Dis; 2015; 19(6):651-6. PubMed ID: 26361839
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    van Griensven J; Mengesha B; Mekonnen T; Fikre H; Takele Y; Adem E; Mohammed R; Ritmeijer K; Vogt F; Adriaensen W; Diro E
    Front Cell Infect Microbiol; 2018; 8():94. PubMed ID: 29651411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.